Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws.
Saturday, May 30
Trending
- GOVERNMENT PARTNERS WITH LOCAL INNOVATORS TO LAUNCH NATIONAL DIGITAL HEALTH INFORMATION SYSTEM
- Ministry of Environment, Climate Action and Constituency Empowerment Launches June Environment Month 2026 with Engaging Activity Line-Up
- St. Kitts and Nevis Pioneers Education for Sustainable Development with UNESCO Support
- REQUEST FOR PROPOSAL – ACQUISITION AND IMPLEMENTATION OF A BUDGETING SYSTEM
- MINISTER HENDERSON HAILS TRANSFORMATIVE WORK IN TOURISM AMID RECORD-BREAKING FIRST QUARTER
- St. Kitts and Nevis VRCP Pilot Featured as Flagship Case Study at High-Level UN Retreat on Operationalizing the Multidimensional Vulnerability Index
- Saint Kitts and Nevis Strengthens Police and Prosecutorial Coordination through National Investigative Training
- REQUEST FOR PROPOSALS: Carrying Capacity Analysis and Visitor Management Plan for St. Kitts

